Oncology: MPA tablets are indicated as an adjunct therapy for: Recurrent and/or metastatic breast cancer; Recurrent and/or metastatic endometrial cancer; Metastatic prostate cancer; Anorexia and cachexia syndrome in patients with severe chronic disorder.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
